微信直播

Prof. Antonio Lacy:固步自封,是TaTME进步最大的绊脚石

Published at: 2015年第1卷第S1期

高凤平 , 冯雁萍
关键词:

编者按:由美国Cleveland Clinic主办的一年一度的消化疾病周(Digestive Disease Institute Week,简称DDI Week)于2月14日至18日在美丽的阳光之州佛罗里达Boca Raton成功举行。该会议是消化病领域的世界级顶尖盛会,历经38年的发展和推广,目前已经成为全球消化病领域过去与未来、热点与难点、东方与西方争锋亮剑的平台。此次,AME出版社有幸邀请到Antonio Lacy教授与我们分享了他对于本次会议热点TaTME的看法,并延伸到减重手术的前沿发展,以及他多年从医的独到体会。

图.  Prof. Lacy(左)与AME编辑(右)合照

作为此次DDI Week会议的参与者之一,Prof. Lacy认为此次会议不仅议程讨论热点丰富,而且更邀请了来自国际的多位消化领域大腕专家共同参与,从质与量上都达到了高水平,对消化疾病治疗的发展有一定影响力。借此,他也不禁感叹,现在的年轻医生拥有更好的资源和途径,如国际大会、互联网、邮箱等,可以接触到来自世界各地优秀的专家,交流互相的想法,这在以前算是天荒夜谭了吧。

此次会议第二日上,设立了关于直肠癌最佳治疗手术选择的专家辩论环节,各专家就此主题热烈讨论了如何去改进目前的直肠癌治疗方法,并提出了研究新疗法时遇到的挑战。关于这个问题,Prof. Lacy分析到,因为TaTME的操作更简单快捷,这无疑是直肠癌的最佳手术选择。

演讲中,Prof. Lacy跟大家一起探讨了TaTME的其他适应症,期间还特意强调了TaTME的定义。令他感慨良多的是,科技的进步和发展往往离不开人才,天时地利人和也是缺一不可,而少部分“权威”的专家意见才是推进TaTME进步的绊脚石。坚持自己的想法固然是一件好事,但是大胆尝试新技术也是当今的“流行趋势”了。

Prof. Lacy还指出,未来直肠癌的关注点应从治疗转移到预防。充分利用好大数据的潜在价值,结合日益俱进的基因检测和基因筛选优势,有望在源头控制直肠癌的患病几率。最后谈到减重手术时,Prof. Lacy结合了不同病人的情况来分析了新技术的优劣,并结合自身的经历来给年轻医生一些宝贵的经验。

更多详情,请猛戳如下视频:

 

采访问题:

Q

Brief self-introuction

Q

Why do you think Transanal Total Mesorectal Excision (taTME) is the best technique for rectal cancer?

Q

Would you like to share the answer and more details about your speech “Are There Other Indications for TaTME Besides Rectal Cancer?”

Q

In your opinion, is there any limitation for TaTME?

Q

What do you think should be the focus of treatment for rectal cancer in the future?

Q

Would you share with us some new techniques for bariatric surgery? What’ll these techniques bring to our patients?

Q

What encourages you to be a surgeon in the colorectal field?

Q

Do you have any suggestions for the young surgeons in the field of colorectal cancer?

专家介绍:

Prof. Antonio M. Lacy, MD, PhD, is chief of the Gastrointestinal Surgery Department at the Hospital Clinic in Barcelona, Professor of the Surgery Department at the School of Medicine of the University of Barcelona, Director of the Surgical Institute of the Hospital Quiron (Barcelona) and President of the Barcelona International Medical Academy (BIMA). He completed his specialty as General Surgeon in 1987, and focused on the surgical treatment of diseases of the gastrointestinal tract (upper GI, colon&rectum, morbid obesity..), with special interest on laparoscopic and minimally invasive surgical techniques (eg NOTES, Reduced Port Surgery –RPS-). Prof.  Lacy has pioneered in some NOTES procedures such as transgastric cholecistectomy, transoral anti-gastroesophagic reflux, transvaginal sygmoidectomy, transvaginal sleeve gastrectomy, and cholecistectomy by RPS. At present, main focus is on transanal, transrectal or transcolonic colorectal surgery. Moreover, he is active member of the international working groups of new techniques for bariatric surgery and development of surgery for Type 2 diabetes and Metabolic Syndrome, with main focus on treatment of Metabolic Syndrome and of patients who gain weight after bariatric surgery. Prof. Lacy has published over 180 manuscripts in specialized journals, as well as more than 20 book chapters. Prof. Lacy is Past president and member of the Executive Board of the European Association for Endoscopic Surgery and other Interventional Techniques (EAES), where he has held different appointments, Active Member of the Society of American Gastrointestinal and Endoscopic Surgeons, Member of the Executive Board of the International Federation of Societies of Endoscopic Surgeons (IFSES), Founding Member of the Multidisciplinary International Rectal Cancer Society and has been unanimously accepted as Honorary Fellow by the American Association of Colorectal Surgeons (ASCRS).

采访编辑 / 高凤平、冯雁萍,AME Publishing Company.

视频编辑 / 麦雪芳,AME Publishing Company.

comments powered by Disqus

附件